Robin Cornelissen Selected Research

Cytoreduction Surgical Procedures

7/2020

Video-assisted biopsy and talc pleurodesis for malignant pleural mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robin Cornelissen Research Topics

Disease

20	Neoplasms (Cancer) 04/2023 - 10/2012
20	Malignant Mesothelioma 01/2023 - 01/2016
14	Mesothelioma 01/2023 - 10/2012
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 12/2010
9	Lung Neoplasms (Lung Cancer) 05/2024 - 12/2010
4	Disease Progression 05/2024 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2021
2	Neutropenia 11/2021 - 01/2021
2	Pain (Aches) 01/2021 - 12/2019
2	Pleural Effusion (Pleural Effusions) 10/2017 - 01/2017
1	Hepatitis 03/2024
1	Emphysema 04/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2022
1	Asthenia 01/2021
1	Cough 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Fatigue 01/2021
1	Heart Failure 01/2021
1	Infections 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Renal Insufficiency (Renal Failure) 01/2020
1	Necrosis 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Acute Tubulointerstitial Nephritis 01/2020
1	Hemorrhage 12/2019
1	Pneumothorax 12/2019
1	Idiopathic Pulmonary Fibrosis 01/2019
1	Lung Diseases (Lung Disease) 01/2019
1	Circulating Neoplastic Cells 10/2017
1	Fever (Fevers) 01/2016
1	Cryptogenic Organizing Pneumonia 01/2007
1	Breast Neoplasms (Breast Cancer) 01/2007
1	Esophagitis 01/2007
1	Radiation Pneumonitis 01/2007

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 04/2023 - 10/2017
4	AsbestosIBA 12/2022 - 12/2017
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
3	NivolumabIBA 05/2024 - 08/2020
3	Pemetrexed (MTA)FDA Link 11/2021 - 12/2010
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 03/2020
2	HM781-36BIBA 01/2023 - 01/2022
2	AntigensIBA 05/2021 - 10/2012
2	Gemcitabine FDA Link 02/2021 - 01/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 01/2016
1	sotorasibIBA 03/2024
1	PM 01183IBA 09/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	pembrolizumabIBA 01/2021
1	IpilimumabIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	PlatinumIBA 01/2021
1	B7-H1 AntigenIBA 08/2020
1	Talc FDA Link 07/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	pirfenidoneIBA 01/2019
1	nintedanibIBA 01/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	CD146 AntigenIBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	LigandsIBA 01/2017
1	AntibodiesIBA 01/2017
1	Complement System Proteins (Complement)IBA 12/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2010

Therapy/Procedure

15	Immunotherapy 03/2024 - 10/2012
15	Therapeutics 01/2023 - 10/2012
11	Drug Therapy (Chemotherapy) 05/2024 - 01/2014
2	Radiotherapy 01/2021 - 01/2007
1	Segmental Mastectomy (Lumpectomy) 06/2021
1	Pleurodesis 07/2020
1	Cytoreduction Surgical Procedures 07/2020
1	Terminal Care (Care, Terminal) 03/2020
1	Chest Tubes (Chest Tube) 12/2019
1	Pneumonectomy (Lung Volume Reduction) 10/2018
1	Operative Surgical Procedures 10/2018
1	Adjuvant Chemotherapy 10/2018
1	Induction Chemotherapy 01/2014